New treatment option for Stroke
Official title Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery
ClinicalTrials.gov ID: NCT06575140
What this study is testing
- What it's testing
- Associative Peripheral Stimulation (APS) is a non-invasive therapy intended for stroke rehabilitation involving transcutaneous electrical muscle stimulation paired with voluntary movement. This pilot study investigates whether APS applied during the acute phase of stroke recovery may reduce impairment and improve function in the affected upper extremity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 79
You may be able to join if
- Confirmed ischemic or hemorrhagic stroke no earlier than 7 days prior to enrollment;
- Presentation of hemiparesis or paralysis of the upper extremity due to stroke;
- Ability to comprehend and follow study instructions;
- Ability to initiate finger extension (≥3°) at least three times per minute;
- Fugl-Meyer Assessment (Upper Extremity) score of \<47.
You likely can't join if
- Contraindications, intolerance, or high sensitivity to the experimental protocol;
- History of upper-extremity disability prior to the index stroke;
- Neurological conditions (other than stroke) affecting motor function;
- Treatment of spasticity/increased tone in the affected upper extremity (e.g., with Botox injection);
- Lack of access to a safe and suitable place of discharge for experimental sessions and follow-up visits.
The study team makes the final eligibility decision.
Where it's taking place
- Mexico City, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.